The boss of communications watchdog Ofcom has given a strong hint that she is against the proposed merger between mobile operator O2 and rival Three because it could lead to higher prices and poorer service. If the $10.2bn (£6.6bn) deal goes through, it would make the combined entity the UK’s largest mobile group, with a 40% market share, and would reduce the number of UK mobile operators from four to three.
In a speech on Wedneesday evening to the London School of Economics and Political Science, Sharon White said that with the planned merger of mobile operators O2 and Three, as well as BT’s plan to buy EE going through, there are “risks to consumers and businesses who have enjoyed one of the most competitive markets of recent years”.
She said there was growing evidence to suggest consumers elsewhere are paying the price for mergers, with mobile prices in Austria, for example, rising by 28% after a 2013 deal reduced the number of networks to three. “Light users of mobile – typically that means older people, children and teenagers – have been hit hardest, seeing prices rise by 38%,” she said.
Full content: The Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas